JP2023545730A5 - - Google Patents

Info

Publication number
JP2023545730A5
JP2023545730A5 JP2023521335A JP2023521335A JP2023545730A5 JP 2023545730 A5 JP2023545730 A5 JP 2023545730A5 JP 2023521335 A JP2023521335 A JP 2023521335A JP 2023521335 A JP2023521335 A JP 2023521335A JP 2023545730 A5 JP2023545730 A5 JP 2023545730A5
Authority
JP
Japan
Prior art keywords
nitrogen
sulfur
oxygen
heteroatoms independently
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023545730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/071762 external-priority patent/WO2022077010A1/en
Publication of JP2023545730A publication Critical patent/JP2023545730A/ja
Publication of JP2023545730A5 publication Critical patent/JP2023545730A5/ja
Pending legal-status Critical Current

Links

JP2023521335A 2020-10-07 2021-10-07 Stat分解剤およびそれらの使用 Pending JP2023545730A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063088787P 2020-10-07 2020-10-07
US63/088,787 2020-10-07
US202063123337P 2020-12-09 2020-12-09
US63/123,337 2020-12-09
PCT/US2021/071762 WO2022077010A1 (en) 2020-10-07 2021-10-07 Stat degraders and uses thereof

Publications (2)

Publication Number Publication Date
JP2023545730A JP2023545730A (ja) 2023-10-31
JP2023545730A5 true JP2023545730A5 (cg-RX-API-DMAC7.html) 2024-10-15

Family

ID=81126142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521335A Pending JP2023545730A (ja) 2020-10-07 2021-10-07 Stat分解剤およびそれらの使用

Country Status (8)

Country Link
US (1) US20240293423A1 (cg-RX-API-DMAC7.html)
EP (1) EP4225303A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023545730A (cg-RX-API-DMAC7.html)
AU (1) AU2021358130A1 (cg-RX-API-DMAC7.html)
CA (1) CA3194492A1 (cg-RX-API-DMAC7.html)
IL (1) IL301830A (cg-RX-API-DMAC7.html)
MX (1) MX2023003973A (cg-RX-API-DMAC7.html)
WO (1) WO2022077010A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102980990B1 (ko) 2019-04-05 2026-06-25 카이메라 쎄라퓨틱스 인코포레이티드 Stat 분해제 및 이의 용도
CN115677831B (zh) * 2021-07-22 2026-03-17 杭州和正医药有限公司 拟肽类stat降解药物、组合物及应用
IL316050A (en) * 2022-03-31 2024-11-01 Recludix Pharma Inc STAT modulators and their uses
WO2024064080A1 (en) * 2022-09-19 2024-03-28 Kymera Therapeutics, Inc. Stat6 degraders and uses thereof
WO2024233639A2 (en) * 2023-05-09 2024-11-14 Recludix Pharma, Inc. Stat degraders and uses thereof
WO2024238603A2 (en) * 2023-05-15 2024-11-21 Recludix Pharma, Inc. Stat degraders and uses thereof
IL326621A (en) * 2023-08-30 2026-04-01 Kymera Therapeutics Inc Stat6 degraders and uses thereof
WO2025217647A1 (en) * 2024-04-12 2025-10-16 Kymera Therapeutics, Inc. Stat6 degraders and uses thereof
WO2026039844A1 (en) * 2024-08-16 2026-02-19 Kymera Therapeutics, Inc. Stat6 degraders and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010077589A2 (en) * 2008-12-08 2010-07-08 The Regents Of The University Of Michigan Office Of Technology Transfer Stat3 inhibitors and therapeutic methods using the same
MX2020003190A (es) * 2017-09-22 2020-11-11 Kymera Therapeutics Inc Degradadores de proteinas y usos de los mismos.
KR20220009941A (ko) * 2019-03-26 2022-01-25 더 리젠츠 오브 더 유니버시티 오브 미시간 Stat3의 저분자 분해제

Similar Documents

Publication Publication Date Title
JP2022527114A5 (cg-RX-API-DMAC7.html)
JP2023518422A5 (cg-RX-API-DMAC7.html)
US12194040B2 (en) FAK inhibitor and drug combination thereof
KR20250029954A (ko) 피리도[4,3-d]피리미딘 화합물
JP2020534375A5 (cg-RX-API-DMAC7.html)
JP2023509366A5 (cg-RX-API-DMAC7.html)
KR20240120744A (ko) 캄프토테신 화합물 및 이의 접합체
JP7671389B2 (ja) Pegmema及び薬物担持ポリマーセグメントから構成される自己集合化ジブロックコポリマー
JP2020517598A5 (cg-RX-API-DMAC7.html)
Song et al. Design and synthesis of novel PEG-conjugated 20 (S)-camptothecin sulfonylamidine derivatives with potent in vitro antitumor activity via Cu-catalyzed three-component reaction
JP2023527962A5 (cg-RX-API-DMAC7.html)
KR20200064059A (ko) 프로그램가능한 수지상 약물
JP2014517017A5 (ja) 化合物、その医薬組成物、及び癌治療用の阻害薬としてのその使用
JP2020512375A5 (cg-RX-API-DMAC7.html)
CA3213692A1 (en) Heterocyclic compounds and uses thereof
JP2020531423A (ja) ヒストンメチルトランスフェラーゼ阻害剤としての三環式化合物
JP7693548B2 (ja) 肺への核酸送達のための犠牲細胞透過性複合体
CN104163823B (zh) 一种喜树碱与青蒿琥酯偶联物及其制备方法与应用
CN104830903A (zh) 一种基于多肽k12的转基因载体及其应用
JP2009502921A5 (cg-RX-API-DMAC7.html)
JP7376694B2 (ja) 再生可能資源に由来するポリマーおよび組成物
CN120435477A (zh) 被取代的3,7-二氢-1h-嘌呤-2,6-二酮及其用途
CN107216362B (zh) 一种阿糖胞苷两亲性小分子前药及其制备方法和应用
CN104910196B (zh) 一种手性四核铜基有机金属框架及其制备方法和应用
CN107998405A (zh) 新型包含难溶性药物的no供体型聚合胶束组合物的制备方法及应用